Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1100 of 1475 entries
View as:

Safety Study of BMS-823778 in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01111955 Org: User:
Start: 07/31/10 End: 01/31/11 Due: 01/31/12

A Study to Evaluate BMS-986036 in Obese Adults With Type-2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02097277 Org: User:
Start: 04/15/14 End: 05/17/16 Due: 05/17/17

A Study of Participants With Squamous Cell Oesophageal Carcinoma Receiving Nivolumab as Part of an Early Access to Medicines Scheme (EAMS) Program in the United Kingdom

Phase: N/A Priority: Normal
NCT ID: NCT04936399 Org: User:
Start: 06/25/20 End: 12/03/21 Due: 12/03/22

Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT00388674 Org: User:
Start: 12/18/06 End: 10/26/16 Due: 10/26/17

Study to Evaluate the Safety, Pharmacokinetics and Target Engagement of BMS-986142 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02257151 Org: User:
Start: 09/30/14 End: 08/31/15 Due: 08/31/16

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Phase: N/A Priority: Normal
NCT ID: NCT01420783 Org: User:
Start: 10/31/11 End: 05/31/14 Due: 05/31/15

A Study to Describe the Switching From a First- or Second-line Disease Modifying Therapy (DMT) to Ozanimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)

Phase: N/A Priority: Normal
NCT ID: NCT05658601 Org: User:
Start: 07/14/23 End: 01/31/27 Due: 01/31/28

A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for Septal Reduction Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04349072 Org: User:
Start: 07/06/20 End: 05/20/24 Due: 05/20/25

A Study to Determine the Safety, Drug Levels and Drug Effects of BMS-986196 and Food and Formulation Effects on Relative Absorption Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04882150 Org: User:
Start: 05/27/21 End: 06/10/22 Due: 06/10/23

A Study to Evaluate the Utilization, Effectiveness, and Quality of Life of Ozanimod in Participants With Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT05382715 Org: User:
Start: 05/30/22 End: 11/30/26 Due: 11/30/27

A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)

Phase: N/A Priority: Normal
NCT ID: NCT06140836 Org: User:
Start: 12/21/23 End: 06/03/27 Due: 06/03/28

Study of the Effects of BMS-919373 on the Electrical Activity of the Heart Using Pacemakers

Phase: N/A Priority: Normal
NCT ID: NCT02153437 Org: User:
Start: 10/30/14 End: 10/20/16 Due: 10/20/17

Pharmacokinetics, Safety and Tolerability of Single-dose Belatacept in Adolescent Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT01791491 Org: User:
Start: 05/09/13 End: 12/06/16 Due: 12/06/17

Assessment of Blood Glucose Changes in Healthy Volunteers After BMS-754807 Alone or BMS-754807 With Metformin

Phase: N/A Priority: Normal
NCT ID: NCT01525823 Org: User:
Start: 02/29/12 End: 04/30/12 Due: 04/30/13

A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05005273 Org: User:
Start: 10/03/22 End: 12/27/22 Due: 12/27/23

Belatacept in Renal Transplantation: Analyses Using Data From the Collaborative Transplant Study

Phase: N/A Priority: Normal
NCT ID: NCT01471223 Org: User:
Start: 03/31/12 End: 08/08/17 Due: 08/08/18

A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT03470922 Org: User:
Start: 04/11/18 End: 12/15/30 Due: 12/15/31

Early Post-marketing Study of Daclatasvir (Daklinza®) + Asunaprevir (Sunvepra®) in the Treatment of Chronic Hepatitis C (CHC) in Adults

Phase: N/A Priority: Normal
NCT ID: NCT03208322 Org: User:
Start: 11/30/18 End: 02/27/19 Due: 02/27/20

Body Weight Effects on Glucophage's Efficacy in Chinese Diagnosed T2DM Patients

Phase: N/A Priority: Normal
NCT ID: NCT00778622 Org: User:
Start: 11/30/09 End: 03/31/11 Due: 03/31/12

An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03338790 Org: User:
Start: 12/19/17 End: 01/10/25 Due: 01/10/26

Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT05478499 Org: User:
Start: 10/06/22 End: 10/17/24 Due: 10/17/25

Drug-Drug Interaction to Study the Effect of BMS-708163 on Pharmacokinetics (PK) of Galantamine Extended Release (ER)

Phase: N/A Priority: Normal
NCT ID: NCT01039194 Org: User:
Start: 01/31/10 End: 04/30/10 Due: 04/30/11

A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00284804 Org: User:
Start: 11/30/05 End: 10/31/09 Due: 10/31/10

A Study of Milvexian Using an IV Microtracer With Additional Formulation and Food Effect Comparison in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04965389 Org: User:
Start: 07/16/21 End: 10/01/21 Due: 10/01/22

Safety and Effectiveness of Nivolumab in Recurring Kidney Cancer Participants

Phase: N/A Priority: Normal
NCT ID: NCT03568435 Org: User:
Start: 02/14/18 End: 12/21/20 Due: 12/21/21